Incidence of some autoimmune diseases in Basrah Province

Nibras S. Al-Ammar; Abeer A. Al-Mawali; Noor Sabeeh; Basil A. Abbas

doi:10.53730/ijhs.v6nS5.10963

Authors

Nibras S. Al-Ammar
nibrasalammar@yahoo.com
College of Medicine, University of Basrah
Abeer A. Al-Mawali College of Medicine, University of Basrah
Noor Sabeeh College of Medicine, University of Basrah
Basil A. Abbas College of Veterinary Medicine, University of Basrah

Keywords:

Rheumatoid arthritis, anti-dsDNA, anti-phospholipids

Abstract

All the patients diagnosed as having autoimmune disease by the clinical examiner and confirmed the diagnosis by laboratory results. Serum samples obtained from patient’s blood and tested for the presence of specific autoantibodies using commercial ELISA kits. Out of 342 patients, 240(70.2%) were diagnosed with celiac disease, 94(27.5%) with Rheumatoid arthritis and 8(2.3%) with Systemic lupus erythematosus (SLE). Results of ELISA test indicated statistically significant increased level of antibodies specific to anti-gliadin (IgA and IgG) and anti-tTg (IgA and IgG) antibodies in patients with celiac disease (p-value< 0.001). Results indicated statistically significant level of (ANA) and (Anti-ccp) in individuals suffering from rheumatoid arthritis. Regarding to (anti-dsDNA), (anti-cardiolipin) and (anti-phospholipids), a statistically significant increased levels detected in individuals with SLE.

Downloads

Download data is not yet available.

References

Adriaanse MPM, Tack GJ, Lima Passos V, Damoiseaux JGM, Schreurs MWJ, van Wiick K, Riedl RG, Masclee AAM, Buurman WA, Mulder CJJ, Vreugdenhil ACE. Serum I-FABP as marker for enterocyte damage in celiac disease and its relation to villous atrophy and circulating autoantibodies. Alimentary Pharmacology & Therapeutics. 2013; 37(4): 482-490.

Aletaha D, Neogi T, Silman A, Funovits J, Felson D, et al., 2010 Rheumatoid Arthritis Classification Criteria. ARTHRITIS & RHEUMATISM. 2010; 62(9): 2569-2581.

Alkazzaz A. Incidence of Rheumatoid arthritis [2001-2011]. The Iraqi Postgraduate Medical Journal. 2013; 12(4).

Al-Rawi AJ, Alazzawi F, Alajili FM, Alwakil R. Rheumatoid arthritis in population samples in Iraq. Annals. Of the Rheumatic diseases. 1978; 37: 73-75.

Arguelles-Grande C, Norman GL, Bhagat G, Green PHR. Hemolysis Interferes with the Detection of Anti-Tissue Transglutaminase Antibodies in Celiac Disease. Clinical Chemistry. 2010; 56(6): 1034-1036.

Arief, A. S., Pattiasina, P. J., & Remus, S. P. (2021). Relevance of human resource management on small business objective in digital era: A critical review of research evidence. International Journal of Social Sciences and Humanities, 5(2), 79–91. https://doi.org/10.29332/ijssh.v5n2.1167

Arif HS, Al-Hadithi R, Abdul Elah S. Some diagnostic aspects of celiac disease in Iraqi children. Iraqi J. Med. Sci. 2009; 7(3): 32-39.),(Firouzi MS, Omrani GR, Khademolhosseini F. Prevalence of Celiac Disease in Shiraz, Southern Iran. Saudi. J. Gastroenterol. 2008; 14(3): 135-138.

Barker C, Mitton C, Jevon G, Mock T. Can Tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005; 115(5): 1341-1346.

Barton SH, Kelly DG, Murray JA. Nutritional deficiencies in celiac disease. Gastroenterol. Clin. North Am. 2007; 36: 93-108.

Baudon JJ, Johanet C, Absalon YB, Morgant G, Cabrol S, Mougenot JF. Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendimysium antibodies. Arch. Pediatr. Adolesc. Med. 2004; 158(6): 584-8.

Bizzaro N, Mazzanti G. Tonutti E, Villalta D, Tozzoli R. Diagnostic Accuracy of the Anti-Citrulline Antibody Assay for Rheumatoid Arthritis. Clinical Chemistry. 2001; 47(6): 1089-1093.

Bonamico M, Tiberty C, Picarelli A. et al. Radioimmunoassay to detect anti-transglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am. Gastroenterol. 2001; 96: 1536-1540.

Cotsapas C, Hafler DA, Immune-mediated disease genetics: the shared basis of pathogenesis. Trends. Immunol. 2013; 34(1): 22-6.

Cummins AG, Roberts-Thomson IC, Prevalence of celiac disease in the Asia-Pacific region. J. Gastroenterol. Hepatol. 2009; 24: 1347-51.

Eisenberg R, Albert D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2006; 2: 20-27.

Erikssson C, Kokkonen H, Rantapää-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northen Sweden. Arthritis Res. Ther. 2011; 13(1): R30.

Eskander, A. E., Subhy, N. S., Abdelfattah, W., & Shamma, R. A. (2022). Antigastric parietal cell antibody as a screening test for Autoimmune gastritis in Egyptian children and adolescents with juvenile autoimmune thyroid disease and those with type 1 diabetes, single center experience. International Journal of Health Sciences, 6(S6), 9685–9695. https://doi.org/10.53730/ijhs.v6nS6.12529

Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. . Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J. Biol. Chem. 2004; 279(17): 17607-16.

Green PH, Cellier C. Celiac disease. N. Engl. J. Med. 2007; 357: 1731-1743.

Harich R, Roger C, Garnier L, Bienvenu J, Fabien N. Comparison of anti-ccp autoantibodies measurement by ELISA and a bead-based assay in a large patients cohort. Clinical Biochemistry. 2014; 47(6): 485-488.

Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008; 58(1): 15-25.

Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Seidman EG, Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2005; 40(1): 1-19.

Hill ID. Clinical Manifestations and diagnosis of Celiac disease in children. Waltham, MA: Up to date; 2008.

Hom G, Graham RR, Modrek B, Tylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapää-Dahlqvist S, Petri M, Manzi S, Seldin MF, Rönnblom L, Syvänen AC, Criswell LA, Gregersen PK, Behrens TW. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 2008; 358(9): 900-9.

Kang JY, Kang A, Green KA, Systemic Review: Worldwide Variation in the frequency of Coeliac Disease and Changes Over Time. Aliment. Pharmacol. Ther. 2013; 38(3): 226-245.

Krause I, Anaya JM, Fraser A, Barzilai O, Ram M, Abad V, Arango A, Garcia J, Shoenfeld Y, Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Annals of the New York Academy of Sciences. 2009; 1173: 633-9.

Masson C. Rheumatoid anemia. Joint Bone Spine. 2011; 78: 131-137.

McMahon MA, Keogan M,O’Connell P, Kearns G. The prevalence of antiphopholipis antibody syndrome among systemic lupus erythematosus patients. Ir. Med. J. 2006; 99: 296-8.

Mortensen ES, Fenton KA, Rekvig OP. Lupus nephritis: the central role of nucleosomes revealed. Am. J. Pathol. 2008; 172(2): 275-83.

Niewinski MM. Advances in celiac disease and gluten-free diet. Assoc. 2008; 108: 661-672.

Noori AS, Jawad AM, Jassim NA, Gorial FI. Prevalence of antiphospholipid antibodies in sample of Iraqi patients with systemic lupus erythematosus: A cross section study. American Journal of Clinical Medicine Research. 2013; 1(4): 61-64.

Petri M. Update on anti-phospholipid antibodies in SLE: the Hopkins Lupus Cohort. Lupus. 2010; 19: 419-23.

Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in United States. Am. J. Gastroenterol. 2012; 107(10): 1537-1545.

Sabahi R, Anlik JH. B-cell-targeted therapy for systemic lupus erythematosus. Drugs. 2006; 66(15): 1933-48.

Simmonds MJ, Gough SC, Genetic insight into disease mechanisms autoimmunity. Br. Med. Bull. 2004; 71: 93-113.

Sollid LM, Molecular basis of celiac disease. Annu. Rev. Immunol. 2000; 18: 53-81.

Song SJ, Iwahashi M, Tomosugi N, Uno K, Yamana J, Yamana S, Isobe T, Ito H, Kawabata H, Yoshizaki K. Comparative evaluation of effects of treatment with tocilizumab and TNF-α inhibitors on serum hepacidin anemia response and disease activity in rheumatoid arthritis patients. Arthritis Research & Therapy. 2013; 15:R141.

Tarr T, Lakos G, Bhattoa HP, et al. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin. Rev. Allergy Immunol. 2007; 32: 131-7.

Thorsby E, Lie BA, HLA associated genetic predisposition to autoimmune diseases Genes involved and possible mechanisms. Transpl. Immunol. 2005; 14: 175-182.

Villalta D, Bizzaro N, Doria A. Anti-dsDNA Antibody isotyes in Systemic Lupus Erythematosus: IgA in addition to IgG anti-dsDNA help to identify Glomerulonephritis and active disease. 2013; 8(8): e71458.